<SEC-DOCUMENT>0001658551-19-000001-index.html : 20191231
<SEC-HEADER>0001658551-19-000001.hdr.sgml : 20191231
<ACCEPTANCE-DATETIME>20191231102159
ACCESSION NUMBER:		0001658551-19-000001
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20191231
DATE AS OF CHANGE:		20191231
EFFECTIVENESS DATE:		20191231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amylyx Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001658551
		IRS NUMBER:				464600503
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-356768
		FILM NUMBER:		191318328

	BUSINESS ADDRESS:	
		STREET 1:		210 BROADWAY
		STREET 2:		#201
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-571-8872

	MAIL ADDRESS:	
		STREET 1:		210 BROADWAY
		STREET 2:		#201
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>